Philips Introduces First Commercial MR-only Solution for Prostate Cancer Treatment Planning in U.S.
March 30, 2016 at 09:13 AM EDT
Royal Philips (NYSE: PHG) today introduced the first commercially available MR-only simulation solution indicated for prostate cancer ...
